Birdwatch Note Rating
2023-06-27 12:17:16 UTC - NOT_HELPFUL
Rated by Participant: AA1524ECBD15C97A1ACCEEDCC0426E1728808014816F8B99D8655E773E76B20D
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details